Micofenolato Mofetilo Normon

Mycophenolate Mofetil, the active ingredient in Micofenolato Mofetilo Normon, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent organ transplant rejection and to manage selected autoimmune disorders by suppressing immune cell activity.

GNH USA supplies Micofenolato Mofetilo Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and clinical use across multiple regions globally.

Mycophenolate Mofetil is used in immunosuppressive regimens to control immune‑mediated processes in transplantation and autoimmune disease.

Organ transplant rejection: prevents acute rejection episodes in kidney, heart and liver transplants. Lupus nephritis: reduces renal inflammation and proteinuria in systemic lupus patients. Graft‑versus‑host disease prophylaxis: lowers the incidence of GVHD after hematopoietic stem‑cell transplantation.

Mycophenolate Mofetil may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea or vomiting - Diarrhea or abdominal discomfort - Headache - Upper respiratory tract infection - Fatigue - Mild elevation of liver enzymes

Serious or Rare Side Effects: - Severe infections (including opportunistic pathogens) - Cytopenias such as leukopenia, anemia or thrombocytopenia - Hepatotoxicity with marked liver enzyme rise - Malignancies, particularly lymphoproliferative disorders - Progressive multifocal leukoencephalopathy (PML) in rare cases

Before initiating therapy, clinicians should assess baseline laboratory values and monitor patients regularly. - Blood count monitoring: perform complete blood counts to detect leukopenia or anemia. - Renal function: evaluate serum creatinine and adjust dose in renal impairment. - Liver enzymes: check hepatic function tests periodically. - Vaccination: avoid live vaccines during treatment. - Contraception: use effective birth control for patients of child‑bearing potential. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mycophenolate Mofetil can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Live vaccines: may cause severe infection. - Antacids containing aluminum or magnesium: reduce drug absorption. - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increases mycophenolate exposure, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Rifampin or other enzyme inducers: lower mycophenolate levels. - Cholestyramine or colestipol: decrease drug bioavailability. - ACE inhibitors or ARBs: may enhance renal adverse effects. - NSAIDs: increase risk of kidney injury when combined.